Profile: Baxter International Inc (BAX.N)

Baxter International Inc. (Baxter), incorporated in 1931, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a diversified healthcare company, Baxter applies a combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, clinical and medical research laboratories, and by patients at home under physician supervision. The Company operates in three segments: The BioScience, Medication Delivery and Renal. The Company’s product portfolio includes anesthesia, biopharmaceuticals, blood collection and transfusion, medication management, oncology, renal and material safety data sheets.

BioScience

The BioScience business manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders. It also manufactures plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies, and vaccines. BioLife Plasma Services is engaged in the collection of plasma that is processed into plasma-based therapies. Baxter operates and maintains numerous plasma collection facilities throughout the United States under the BioLife name, as well as a number of facilities in Europe.

Medication Delivery

The Medication Delivery business manufactures intravenous (IV) solutions and administration sets. It also manufactures premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies.

Renal

The Renal business provides products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures peritoneal dialysis (PD) solutions and other products for PD, a home-based dialysis therapy, and also distributes products for hemodialysis (HD), which is generally conducted in a hospital or clinic. The Company offers a range of services to support kidney patients in the community.